NEW AIDH DIGITAL STRATEGY ADDS PILLAR TO PREVIOUS AIMS Nurturing, supporting and advancing AIDH members’ professional lives
With
Anja Nikolic,
Chief Executive Officer
Australasian Institute of Digital Health
SEGMENT
Filmed in Melbourne & Sydney | March 2026
Australasian Institute of Digital Health (AIDH), today has released the AIDH Strategic Plan for 2026–2028, recently approved by the Board. This plan acts as a roadmap, as well as a shared statement of purpose and intent, guiding where AIDH will focus its effort, investment and voice over the next three years.
Australian Health Journal spoke with Anja Nikolic, AIDH Chief Executive Officer on AIDH’s role as a hub for collaboration, knowledge advancement and thought leadership across the sector.
Drawing upon the previous strategic plan ending 2025, the new plan as a new pillar.
The plan commits AIDH to continuing its work in building a highly skilled and capable workforce, shaping healthcare through strong thought leadership, and fostering a diverse and engaged community. Importantly, it introduces an additional strategic aim — nurturing a thriving and growing membership — because its impact relies on a strong, supported and connected member base.
Underlying themes are AIDH’s commitment to organisational excellence, guided by its values of professionalism, excellence, integrity, respect and teamwork.
The Strategic Plan was developed collaboratively, drawing on the insight and experience of staff, the Board, members and stakeholders.
AIDH members and stakeholders are invited to read the plan and consider how they can support its delivery — through their involvement, their ideas, and their advocacy for AIDH and the digital health community.
Source: Supplied and adapted
You Might also like
-
Foundation outlines breast cancer research strategy
Australian Health Journal met with Associate Professor Cleola Anderiesz, CEO of the National Breast Cancer Foundation to hear of the new 5 year Pink Horizon research strategy. Those with lived experience of breast cancer, along with researchers, clinicians, and other funding organisations, have contributed to the development of the foundation’s new five-year Pink Horizon research strategy. This ambitious plan aims to invest $125 million to accelerate research efforts towards the vision of ending deaths from breast cancer.
-
Reflecting on a pivotal year for pharmacy
Dr. Kate Wang, a Senior Lecturer in Pharmacy at RMIT University and Adjunct Senior Lecturer, University of Western Australia, has over a decade of experience in both hospital and community pharmacy settings.
Dr Wang spoke to Australian Health Journal on some of the key topics in 2024 that have been pivotal as a pharmacist, academic and researcher for the pharmacy profession.
-
Research funded to investigate early-onset bowel cancer progression
Bowel Cancer Australia recently announced a team led by Professor Michael Samuel as the successful applicant for a three-year $600k early-onset bowel cancer research project through the 2023 round of Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS).